Foehr Matthew W |
President and CEO |
OmniAb, Inc. (OABI)
|
2024-05-24 |
$4.42 |
-6.9% |
240,000
|
$1,059,840 |
Foehr Matthew W |
President and CEO |
OmniAb, Inc. (OABI)
|
2024-03-22 |
$5.19 |
-20.8% |
225,000
|
$1,167,750 |
Foehr Matthew W |
Chief Executive Officer |
OmniAb, Inc. (OABI)
|
2023-12-12 |
$5.05 |
-18.6% |
200,000
|
$1,010,000 |
Foehr Matthew W |
President and CEO |
OmniAb, Inc. (OABI)
|
2023-11-10 |
$4.27 |
-3.7% |
95,000
|
$405,517 |
Foehr Matthew W |
President and CEO |
OmniAb, Inc. (OABI)
|
2023-08-14 |
$5.48 |
-25.0% |
45,000
|
$246,600 |
Foehr Matthew W |
Chief Executive Officer |
OmniAb, Inc. (OABI)
|
2023-06-09 |
$4.52 |
-9.1% |
115,000
|
$519,800 |
Foehr Matthew W |
Chief Executive Officer |
OmniAb, Inc. (OABI)
|
2023-05-12 |
$3.40 |
20.9% |
440,000
|
$1,496,000 |
Foehr Matthew W |
President |
OmniAb, Inc. (OABI)
|
2022-12-12 |
$3.77 |
9.2% |
150,000
|
$564,765 |
Foehr Matthew W |
President |
OmniAb, Inc. (OABI)
|
2022-11-30 |
$3.39 |
21.3% |
300,000
|
$1,016,340 |
Foehr Matthew W |
President |
OmniAb, Inc. (OABI)
|
2022-11-09 |
$2.76 |
48.8% |
100,000
|
$276,160 |
Foehr Matthew W |
President and COO |
LIGAND PHARMACEUTICALS INC (LGND)
|
2022-05-13 |
$82.76 |
24.6% |
2,500
|
$206,910 |
Foehr Matthew W |
Non-Executive Director |
Viking Therapeutics, Inc. (VKTX)
|
2022-05-02 |
$2.47 |
2141.6% |
45,000
|
$111,195 |
Foehr Matthew W |
Non-Executive Director |
Viking Therapeutics, Inc. (VKTX)
|
2021-06-10 |
$5.69 |
873.5% |
20,000
|
$113,800 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
42.9% |
$3,513,648 |
$8,194,677 |